mibefradil   Click here for help

GtoPdb Ligand ID: 2522

Synonyms: Posicor® | Ro-405967-001
Approved drug PDB Ligand
mibefradil is an approved drug (FDA (1997))
Compound class: Synthetic organic
Comment: Marketed formulations contained mibefradil dihydrochloride (PubChem CID 60662).
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 5
Hydrogen bond donors 1
Rotatable bonds 12
Topological polar surface area 67.45
Molecular weight 495.29
XLogP 5.1
No. Lipinski's rules broken 2
Click here for help
Canonical SMILES COCC(=O)OC1(CCN(CCCc2nc3c([nH]2)cccc3)C)CCc2c(C1C(C)C)ccc(c2)F
Isomeric SMILES COCC(=O)O[C@]1(CCN(CCCc2nc3c([nH]2)cccc3)C)CCc2c([C@@H]1C(C)C)ccc(c2)F
InChI InChI=1S/C29H38FN3O3/c1-20(2)28-23-12-11-22(30)18-21(23)13-14-29(28,36-27(34)19-35-4)15-17-33(3)16-7-10-26-31-24-8-5-6-9-25(24)32-26/h5-6,8-9,11-12,18,20,28H,7,10,13-17,19H2,1-4H3,(H,31,32)/t28-,29-/m0/s1
No information available.
Summary of Clinical Use Click here for help
This drug was approved to treat hypertension and chronic angina pectoris, but was withdrawn after only one year due to the risk of potentially fatal effects caused by interaction with other drugs.
Mechanism Of Action and Pharmacodynamic Effects Click here for help
Mibefradil is a nonselective calcium channel blocker.